Your session is about to expire
← Back to Search
Deep Brain Stimulation for Obsessive-Compulsive Disorder
This trial is for participants that have been diagnosed with intractable Obsessive-compulsive disorder (OCD) and want to develop an adaptive Deep Brain Stimulation (aDBS) system.
- Obsessive-Compulsive Disorder
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any open slots left for participants in this trial?
"Per the information hosted on clinicaltrials.gov, this trial is not presently seeking new participants. The study was initially posted on July 1st 2021 and last modified on September 12th 2022. Although it does not appear that this particular medical research project requires more patients, there are nearly a thousand other trials actively enrolling at present."
To what demographic does this medical experiment cater?
"This clinical trial is recruiting five individuals, aged 18 to 70, with a documented history of Obsessive-Compulsive Disorder (OCD). Participants must have unsuccessfully trialled augmentation therapy featuring one of the following antipsychotics: Haloperidol; Risperidone; Quetiapine; Ziprasidone or Aripiprazole. Additionally, they should have been exposed to at least 25 hours of Exposure and Response Prevention (ERP) Therapy by an accredited therapist but still struggle to manage their OCD symptoms which cause significant distress or impairment in daily life. The participants' diagnoses are verified through scoring 28"
Is this medical trial open to participants aged eighty or below?
"This clinical trial adheres to the following age parameters: 18 is the minimum entry requirement while 70 marks the upper limit."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends